Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics

Journal of Experimental Medicine

Volumn 207, Issue 7, 2010, Pages 1475-1483

  Thangada, Shobha ^b   Khanna, Kamal M ^b   Blaho, Victoria A ^a   Oo, Myat Lin ^a   Im, Dong Soon ^b   Guo, Caiying ^c   Lefrancois, Leo ^b   Hla, Timothy ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL KINETICS; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HOMEOSTASIS; INTERNALIZATION; LYMPHOCYTE MIGRATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; ENDOCYTOSIS; KINETICS; LYMPHOPENIA; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; T-LYMPHOCYTES;

EID: 77954421069     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091343     Document Type: Article

References (52)

1. Allende, M.L., and R.L. Proia. 2002. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim. Biophys. Acta. 1582:222-227.
2. Allende, M.L., J.L. Dreier, S. Mandala, and R.L. Proia. 2004. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279:15396-15401. doi:10.1074/jbc.M314291200
3. Ammit, A.J., A.T. Hastie, L.C. Edsall, R.K. Hoffman, Y. Amrani, V.P. Krymskaya, S.A. Kane, S.P. Peters, R.B. Penn, S. Spiegel, and R.A. Panettieri Jr. 2001. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15:1212-1214.
4. Bandhuvula, P., and J.D. Saba. 2007. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Trends Mol. Med. 13:210-217. doi:10.1016/j.molmed.2007.03.005
5. Bandhuvula, P., Y.Y. Tam, B. Oskouian, and J.D. Saba. 2005. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280:33697-33700. doi:10.1074/jbc.C500294200
6. Brinkmann, V., M.D. Davis, C.E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:21453-21457. doi:10.1074/jbc.C200176200
7. Brinkmann, V., J.G. Cyster, and T. Hla. 2004. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant. 4:1019-1025. doi:10.1111/j.1600-6143.2004. 00476.x
8. Chiba, K. 2005. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol. Ther. 108:308-319. doi:10.1016/j.pharmthera.2005.05.002
9. Cohen, J.A., F. Barkhof, G. Comi, H.P. Hartung, B.O. Khatri, X. Montalban, J. Pelletier, R. Capra, P. Gallo, G. Izquierdo, et al; TRANSFORMS Study Group. 2010. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362:402-415. doi:10.1056/NEJMoa0907839
10. Cyster, J.G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127-159. doi:10.1146/annurev.immunol.23.021704.115628
11. Deutschman, D.H., J.S. Carstens, R.L. Klepper, W.S. Smith, M.T. Page, T.R. Young, L.A. Gleason, N. Nakajima, and R.A. Sabbadini. 2003. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am. Heart J. 146:62-68. doi:10.1016/S0002-8703(03)00118-2
12. Gräler, M.H., and E.J. Goetzl. 2004. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18:551-553.
13. Grigorova, I.L., S.R. Schwab, T.G. Phan, T.H. Pham, T. Okada, and J.G. Cyster. 2009. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat. Immunol. 10:58-65. doi:10.1038/ni.1682
14. Hanyaloglu, A.C., and M. von Zastrow. 2008. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu. Rev. Pharmacol. Toxicol. 48:537-568. doi:10.1146/annurev.pharmtox.48.113006.094830
15. Hla, T. 2001. Sphingosine 1-phosphate receptors. Prostaglandins Other Lipid Mediat. 64:135-142. doi:10.1016/S0090-6980(01)00109-5
16. Hla, T. 2004. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 15:513-520. doi:10.1016/j.semcdb.2004.05.002
17. Ishii, M., J.G. Egen, F. Klauschen, M. Meier-Schellersheim, Y. Saeki, J. Vacher, R.L. Proia, and R.N. Germain. 2009. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 458:524-528. doi:10.1038/nature07713
18. Jo, E., M.G. Sanna, P.J. Gonzalez-Cabrera, S. Thangada, G. Tigyi, D.A. Osborne, T. Hla, A.L. Parrill, and H. Rosen. 2005. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12:703-715. doi:10.1016/j.chembiol.2005.04.019
19. Kabashima, K., N.M. Haynes, Y. Xu, S.L. Nutt, M.L. Allende, R.L. Proia, and J.G. Cyster. 2006. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203:2683-2690. doi:10.1084/jem.20061289
20. Khanna, K.M., C.C. Aguila, J.M. Redman, J.E. Suarez-Ramirez, L. Lefrançois, and L.S. Cauley. 2008. In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection. Eur. J. Immunol. 38:3304-3315. doi:10.1002/eji.200838602
21. Kitano, M., T. Hla, M. Sekiguchi, Y. Kawahito, R. Yoshimura, K. Miyazawa, T. Iwasaki, H. Sano, J.D. Saba, and Y.Y. Tam. 2006. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum. 54:742-753. doi:10.1002/art.21668
22. Ledgerwood, L.G., G. Lal, N. Zhang, A. Garin, S.J. Esses, F. Ginhoux, M. Merad, H. Peche, S.A. Lira, Y. Ding, et al. 2008. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9:42-53. doi:10.1038/ni1534
23. Lee, M.J., S. Thangada, J.H. Paik, G.P. Sapkota, N. Ancellin, S.S. Chae, M. Wu, M. Morales-Ruiz, W.C. Sessa, D.R. Alessi, and T. Hla. 2001. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell. 8:693-704. doi:10.1016/S1097-2765(01) 00324-0
24. Liu, C.H., S. Thangada, M.J. Lee, J.R. Van Brocklyn, S. Spiegel, and T. Hla. 1999. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol. Biol. Cell. 10:1179-1190.
25. Liu, P., N.A. Jenkins, and N.G. Copeland. 2003. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13:476-484. doi:10.1101/gr.749203
26. Lo, C.G., T.T. Lu, and J.G. Cyster. 2003. Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 197:353-361. doi:10.1084/jem.20021569
27. Mamdouh, Z., A. Mikhailov, and W.A. Muller. 2009. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J. Exp. Med. 206:2795-2808. doi:10.1084/jem.20082745
28. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:346-349. doi:10.1126/science.1070238
29. Marchese, A., M.M. Paing, B.R.S. Temple, and J. Trejo. 2008. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 48:601-629. doi:10.1146/annurev.pharmtox.48.113006.094646 (Pubitemid 351738165)
30. Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo, E.A. Moseman, I.V. Huff, T. Junt, A.J. Wagers, I.B. Mazo, and U.H. von Andrian. 2007. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell. 131:994-1008. doi:10.1016/j.cell.2007.09.047
31. Matloubian, M., C.G. Lo, G. Cinamon, M.J. Lesneski, Y. Xu, V. Brinkmann, M.L. Allende, R.L. Proia, and J.G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 427:355-360. doi:10.1038/nature02284
32. Mechtcheriakova, D., A. Wlachos, J. Sobanov, F. Bornancin, G. Zlabinger, T. Baumruker, and A. Billich. 2007. FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. FEBS Lett. 581:3063-3068. doi:10.1016/j.febslet. 2007.05.069
33. Muller, W.A. 2009. Mechanisms of transendothelial migration of leukocytes. Circ. Res. 105:223-230. doi:10.1161/CIRCRESAHA.109.200717
34. Oo, M.L., S. Thangada, M.T. Wu, C.H. Liu, T.L. Macdonald, K.R. Lynch, C.Y. Lin, and T. Hla. 2007. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem. 282:9082-9089. doi:10.1074/jbc. M610318200
35. Pan, S., Y. Mi, C. Pally, C. Beerli, A. Chen, D. Guerini, K. Hinterding, B. Nuesslein-Hildesheim, T. Tuntland, S. Lefebvre, et al. 2006. A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem. Biol. 13:1227-1234. doi:10.1016/j.chembiol.2006.09.017
36. Pham, T.H., T. Okada, M. Matloubian, C.G. Lo, and J.G. Cyster. 2008. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity. 28:122-133. doi:10.1016/j.immuni.2007.11.017
37. Rivera, J., R.L. Proia, and A. Olivera. 2008. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat. Rev. Immunol. 8:753-763. doi:10.1038/nri2400
38. Rosen, H., P. Gonzalez-Cabrera, D. Marsolais, S. Cahalan, A.S. Don, and M.G. Sanna. 2008. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol. Rev. 223:221-235. doi:10.1111/j.1600-065X.2008. 00645.x
39. Sachpatzidis, A., B.K. Benton, J.P. Manfredi, H. Wang, A. Hamilton, H.G. Dohlman, and E. Lolis. 2003. Identification of allosteric peptide agonists of CXCR4. J. Biol. Chem. 278:896-907. doi:10.1074/jbc.M204667200
40. Sanchez, T., T. Estrada-Hernandez, J.H. Paik, M.T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278:47281-47290. doi:10.1074/jbc. M306896200
41. Schwab, S.R., and J.G. Cyster. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8:1295-1301. doi:10.1038/ni1545
42. Schwab, S.R., J.P. Pereira, M. Matloubian, Y. Xu, Y. Huang, and J.G. Cyster. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 309:1735-1739. doi:10.1126/science.1113640
43. Sebzda, E., Z. Zou, J.S. Lee, T. Wang, and M.L. Kahn. 2008. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol. 9:292-300. doi:10.1038/ni1565
44. Singer, I.I., M. Tian, L.A. Wickham, J. Lin, S.S. Matheravidathu, M.J. Forrest, S. Mandala, and E.J. Quackenbush. 2005. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol. 175:7151-7161.
45. Sinha, R.K., C. Park, I.Y. Hwang, M.D. Davis, and J.H. Kehrl. 2009. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis. Immunity. 30:434-446. doi:10.1016/j.immuni.2008.12.018
46. Vroon, A., C.J. Heijnen, and A. Kavelaars. 2006. GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80:1214-1221. doi:10.1189/jlb.0606373
47. Walzer, T., L. Chiossone, J. Chaix, A. Calver, C. Carozzo, L. Garrigue-Antar, Y. Jacques, M. Baratin, E. Tomasello, and E. Vivier. 2007. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 8:1337-1344. doi:10.1038/ni1523
48. Watterson, K.R., E. Johnston, C. Chalmers, A. Pronin, S.J. Cook, J.L. Benovic, and T.M. Palmer. 2002. Dual regulation of EDG1/S1P(1) receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2. J. Biol. Chem. 277:5767-5777. doi:10.1074/jbc.M110647200
49. Wei, S.H., H. Rosen, M.P. Matheu, M.G. Sanna, S.K. Wang, E. Jo, C.H. Wong, I. Parker, and M.D. Cahalan. 2005. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6:1228-1235. doi:10.1038/ni1269
50. Weninger, W., and U.H. von Andrian. 2003. Chemokine regulation of naïve T cell traffic in health and disease. Semin. Immunol. 15:257-270. doi:10.1016/j.smim.2003.08.007
51. Yamanaka, M., Y. Anada, Y. Igarashi, and A. Kihara. 2008. A splicing isoform of LPP1, LPP1a, exhibits high phosphatase activity toward FTY720 phosphate. Biochem. Biophys. Res. Commun. 375:675-679. doi:10.1016/j.bbrc.2008. 07.165
52. Zemann, B., B. Kinzel, M. Müller, R. Reuschel, D. Mechtcheriakova, N. Urtz, F. Bornancin, T. Baumruker, and A. Billich. 2006. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood. 107:1454-1458. doi:10.1182/blood-2005-07-2628 (Pubitemid 43242381)